Schizophrenia: Redox Regulation and Volume Neurotransmission

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|9|2|289-300

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.9, Iss.2, 2011-06, pp. : 289-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia

By Heresco-Levy Uriel  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 827-844

Informa Healthcare

Access to resources Recommend Favorite

Is Dopamine Neurotransmission Altered in Prodromal Schizophrenia? A Review of the Evidence

By  

Current Pharmaceutical Design, Vol. 18, Iss. 12, 2012-04 ,pp. : 1568-1579

Bentham Science Publishers

Access to resources Recommend Favorite

Epilepsy, Regulation of Brain Energy Metabolism and Neurotransmission

By  

Current Medicinal Chemistry, Vol. 16, Iss. 7, 2009-03 ,pp. : 841-853

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of GABA Neurotransmission by Glutamic Acid Decarboxylase (GAD)

By  

Current Pharmaceutical Design, Vol. 21, Iss. 34, 2015-10 ,pp. : 4939-4942

Bentham Science Publishers

Access to resources Recommend Favorite

Redox regulation of the immune response

By Gostner Johanna M  

Redox Report, Vol. 18, Iss. 3, 2013-05 ,pp. : 88-94

Maney Publishing

Access to resources Recommend Favorite